PF-3758309 is an experimental anticancer drug which acts as an inhibitor of p21-activated kinases with highest affinity for PAK4. It shows activity against a variety of different cancer types including colon, lung and pancreatic cancers, and is in early stage clinical trials.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.